戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 lation between abuse and low birth weight in full term infants.
2 nces in eye structure and vision compared to full-term infants.
3 fants harbor a different gut microbiome than full-term infants.
4 eeks, supplemented with a reference group of full-term infants.
5 r disadvantages in iron status among healthy full-term infants.
6 2 months of life were distinct from those of full-term infants.
7 re frequently than cries in both preterm and full-term infants.
8  with neurodevelopmental outcomes in healthy full-term infants.
9 that differentiate them from sham stimuli in full-term infants.
10 yse associated factors in former preterm and full-term infants.
11 ity of poor cognitive outcomes compared with full-term infants.
12 ere collected from 18 mothers of pre-term or full-term infants.
13  value was high despite a low recall rate in full-term infants.
14  (< 2,500 g), and birth weight (grams) among full-term infants.
15 ociation between PFOS and birth weight among full-term infants.
16 m infants were also more Th2 skewed than the full-term infants.
17 tion may adversely affect birth weight among full-term infants.
18  as issues pertaining to feeding preterm and full-term infants.
19 ants, and by $5404 (95% CI, $5110-$5698) for full-term infants.
20 m the umbilical cord veins of their healthy, full-term infants.
21 d cerebral palsy or cPVL in both preterm and full-term infants.
22 n in RA women after disease onset) and small full-term infants.
23  compared with results from our database for full-term infants.
24 t formula affects the iron status of healthy full-term infants.
25 , weight, or length among generally healthy, full-term infants.
26  had lower baseline RSV antibody levels than full-term infants.
27 terferon signatures compared with cells from full-term infants.
28 tic hypothermia in nonvigorous near-term and full-term infants.
29  1989, along with a control group of healthy full-term infants.
30                           The recall rate in full-term infants (0.03%) was lower than that in preterm
31 y premature infant costs 5.6 times that of a full-term infant ($10 214), full-term infants accounted
32                          Overall, 4/264 (2%) full-term infants, 15/125 (12%) preterm-infants with GA
33  double-blind study, 183 healthy preterm and full-term infants 2 weeks to 8 months of age were random
34                         Results Thirty-eight full-term infants (20 boys, 18 girls) underwent MRI exam
35 association between PFOS and birth weight in full-term infants (-29 g per log unit increase; 95% CI:
36                                           In full-term infants, 336 (53.4%) of those receiving surfac
37                          Among 125 singleton full-term infants, 4 (3.2%) had low birth weights.
38  (mean +/- SD, 26.1 +/- 13.8%) compared with full-term infants (7.3 +/- 8.2%; P = 0.020) and prematur
39 able for 226 preterm infants (88.6%) and 144 full-term infants (90.6%).
40                                        Among full-term infants, a positive association was found betw
41  times that of a full-term infant ($10 214), full-term infants accounted for 82% of RSVHs and 70% of
42        The population included near-term and full-term infants aged 35 to 42 weeks' gestation at birt
43                                           40 full-term infants aged 6 months and younger were given v
44 ed in a forward-masking paradigm in healthy, full-term infants aged 6 weeks (n = 111) and 9 months (n
45                                     Eighteen full-term infants (aged 8-12 wk at enrollment) were fed
46                         For both preterm and full-term infants, ages 18 to 23 weeks were associated w
47 Y, respectively (13.4/100 and 5.8/100 CY for full-term infants and 20/100 and 6.8/100 CY for late pre
48    The authors recorded VEPs from 57 healthy full-term infants and 4 adults.
49 ity of handheld SD OCT imaging of the ONH in full-term infants and children without anaesthesia or se
50 eeded for otherwise healthy, late-preterm to full-term infants and children.
51 nutrient additions to a formula designed for full-term infants and donor or maternal milk.
52 erate the number of T cells was performed on full-term infants and preterm infants when they reached
53 )2 skewing of central memory-like T cells in full-term infants, and B cells from 2-month-old EPIs exh
54 microbiome colonization patterns relative to full-term infants, and it is speculated that the hospita
55  of birth is recognised in about one in 4000 full-term infants, and may present with neurological and
56                                              Full-term infants are the predominant source of infant R
57             Randomized clinical trial of 382 full-term infants born after a low-risk pregnancy at a S
58  included in the original study (n = 382) as full-term infants born after a low-risk pregnancy were i
59                 A total of 145,456 singleton full-term infants born alive and whose mothers were cove
60                            A total of 14,189 full-term infants born in the United Kingdom on April 5
61   The results of this study suggest that for full-term infants, breast-feeding is associated with enh
62 nt risk factors for low birth weight for the full term infants but not the preterm infants on a bivar
63 t infants and 534 were non-low-birth-weight, full-term infants (control).
64 lk composition, or both may be modulators of full-term infant development.
65                                   6-week-old full-term infants due for their first polio vaccinations
66 increased ED visit risk for both preterm and full-term infants during the first year of life, which m
67  received non-selenium-fortified preterm and full-term infant formulas containing 0.12 and 0.11 mumol
68 2 g) received selenate-fortified preterm and full-term infant formulas containing 0.36 and 0.22 mumol
69                                              Full-term infants from 2 to 4 months of age and pre-pres
70 eterm infant (preterm women), or delivered a full-term infant (full-term women).
71  (gestational age <=31 weeks) and 51 healthy full-term infants (gestational age 38-42 weeks).
72 y preterm infants (<32 weeks' gestation) and full-term infants (&gt;=37 weeks' gestation) born in New So
73                                 Some healthy full-term infants have bilateral subfoveal fluid not obv
74  most common cause of neonatal meningitis in full-term infants (herein NMEC) and the most common caus
75  why disease severity differs among healthy, full-term infants; however, virus titers, inflammation,
76 ping of the umbilical cord of normal-weight, full-term infants improved iron and haematological statu
77 RS-CoV-2 antibodies in preterm compared with full-term infants in association with vaccination timing
78 matic review of articles relevant to healthy full-term infants in countries with a high or very high
79 lies in Honduras, 3) low-birth-weight (LBW), full-term infants in Honduras, and 4) infants in Ghana.
80 otein, which has been studied in preterm and full-term infants in the phase 2b and phase 3 MELODY tri
81    The probability of low birth weight among full-term infants in the population was estimated using
82 ncytial virus (RSV) burden among preterm and full-term infants in the United States.
83 -fovea distance were measured in preterm and full-term infants in vivo.
84                                Compared with full-term infants, lymphocytes from preterm infants had
85 e dramatically different from those in which full-term infants mature and thus likely impact the deve
86 hen offered more frequent feedings, healthy, full-term infants may overeat.
87 s 2.0 for each scan; 43 male infants) and 22 full-term infants (mean PMA, 42.1 weeks 2.0; 13 male inf
88                               A total of 159 full-term infants (median [IQR] GA, 40 weeks 0 days [39
89 ne, p < 0.05) than did children who had been full-term infants of normal birthweight.
90 patient-years (95% CI, 14.9-17.4) for 33 417 full-term infants (P < .001).
91 t age was significantly higher compared with full-term infants (P .02).
92 ood T lymphocytes from preterm compared with full-term infants (P = 0.008).
93 ency of miscarriage, premature births, small full-term infants, perinatal deaths, and births of live
94 , 2 days to 46 weeks, 1 day] for preterm and full-term infants, respectively).
95                                              Full-term infants show a decline in their discrimination
96 ent RNFL thickness measurements for healthy, full-term infants that may serve as normative data for f
97 children who had been normal birthweight and full-term infants, the cromolyn without steroids group h
98 ed for gestational age or were restricted to full-term infants to separate effects of fetal growth fr
99                               As compared to full-term infants, VPT infants exhibited significant glo
100 al age, the number of hospitalizations among full-term infants was 60 cases pre-policy and 62 cases p
101  age, the number of hospitalizations amongst full-term infants was 60 cases pre-policy and 62 cases p
102                                        Fifty full-term infants were adequately imaged for RNFL analys
103 three longitudinal MRI scans, and 22 healthy full-term infants were enrolled for one term MRI scan be
104 e milk of mothers giving birth to preterm or full-term infants were not significantly different.
105        Primiparous breastfeeding mothers and full-term infants were randomly assigned to receive rela
106 wever, adequate to meet the calcium needs of full-term infants when the formula's calcium content is
107 cits of cerebral palsy (CP) in premature and full-term infants who present with neonatal encephalopat
108 ized clinical trial among late near-term and full-term infants who were nonvigorous at birth, ASQ-3 s
109                        94 VPT infants and 46 full-term infants with high-quality T2-weighted MRI were
110      In a prospective, multicenter study, 58 full-term infants with severe hypoxemia and persistent p
111             Inclusion criteria were healthy, full-term infants with weight appropriate for gestationa
112 hort study included all liveborn, singleton, full-term infants without malformations born in Denmark
113 nd feasibility phase 1/2 trial, we recruited full-term infants younger than 48 h who had hypoxic isch
114 brile (>/=38 degrees C), previously healthy, full-term infants younger than 60 days for whom blood cu

 
Page Top